Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 226
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/29/2008
 
First Published:
12/8/2006
1.
Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV, Phase III
Treatment
Active
21 and under
Other
GPOH-NB2004
EU-20661, NCT00410631
2.
Prevention of Cyclophosphamide, Hydroxydaunorubicin (Adriamycin), Oncovin (Vincristine), Prednisone/Prednisolone (CHOP)-Induced Chronic Cardiotoxicity
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Active
15 to 70
Other
OLSG-0401
NCT00162955
3.
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
18 to 75
Other
ADO-MM-PAL8
NCT00226473
4.
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
Over 55
Other
GMALL02
NCT00198978
5.
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL01
NCT00198991
6.
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL03
NCT00199004
7.
Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
Over 15
Other
GMALL05
NCT00199082
8.
Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
16 to 75
Other
CGC05MK1002
NCT00188149
9.
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 60
Other
Hemato INCAN 01/2007
NCT00429065
10.
Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
18 to 70
Other
2006-003750-23
LINFOTARGAM, NCT00466258
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute